A History of Drug Metabolism in the United Kingdom

References

• Bachman C., Bickel M. H. History of drug metabolism: The first half of the 20th century. Drug Metab. Rev. 1985; 16: 185–253
   PubMed Web of Science ®Google Scholar
• Goodwin T. W. History of the Biochemical Society, 1911–1986. Biochemical Society, London 1987
   Google Scholar
• Williams R. T. Detoxication Mechanisms, 2nd ed. Chapman and Hall, London 1959
   Google Scholar
• Parke D. V. Radioisotopes in the study of the metabolism of foreign compounds. Isotopes in Experimental Pharmacology, L. J. Roth. University of Chicagov Press, Chicago 1965
   Google Scholar
• Parke D. V., Williams R. T. Studies in Detoxication. 49. The metabolism of benzene containing [14C1)benzene. Biochem. J. 1953; 54: 231–238
   PubMed Web of Science ®Google Scholar
• Needham J., Baldwin E. Hopkins and Biochemistry, 1861–1947. Heffer, Cambridge 1949
   Google Scholar
• Neuberger A., Smith R. L. Richard Tecwyn Williams: The man, his work, his impact. Drug Metab. Rev. 1983; 14: 559–607
   PubMed Web of Science ®Google Scholar
• Channon H. J., Mills G. T., Williams R. T. The metabolism of 2:4:6-trinitrotoluene. Biochem. J. 1944; 38: 70–85
   PubMedGoogle Scholar
• Williams R. T. The metabolism of sulphonamides. Part 2. The isolation and identification of 3-hydroxysulphanilamide as the oxidation product of sulphanilamide in the rabbit. Biochem. J. 1946; 40: 219–222
   Web of Science ®Google Scholar
• Porteous J. W., Williams R. T. Studies in Detoxication 19. The metabolism of benzene. 1. (a) The determination of phenol in urine with 2:6-dichloroquinone chloroimide, (b) the excretion of phenol glucuronic acid and ethereal sulphate by rabbits receiving benzene orally. Biochem. J. 1949; 44: 46–55
   Web of Science ®Google Scholar
• Smith J. N., Williams R. T. Studies in Detoxication. 16. The metabolism of acetanilide in the rabbit. Biochem. J. 1948; 42: 538–544
   PubMed Web of Science ®Google Scholar
• Smith J. N., Williams R. T. Studies in Detoxication. 22. The metabolism of phenacetin in the rabbit, and a further observation on acetanilide metabolism. Biochem. J. 1949; 44: 239–242
   Web of Science ®Google Scholar
• Smith J. N.J. N., Williams R. T. Studies in Detoxication. 23. The fate of aniline in the rabbit. Biochem. J. 1949; 44: 242–250
   Web of Science ®Google Scholar
• Dodgson K. S., Williams R. T. The isolation of stilboestrol glucuronide from human urine. Nature (Lond.) 1948; 161: 604
   PubMed Web of Science ®Google Scholar
• Williams R. T. Detoxication Mechanisms. Chapman and Hall, London 1947
   Google Scholar
• Elliott T. H., Parke D. V., Williams R. T. The metabolism of [14C]cyclohexane and its derivatives. Biochem. J. 1959; 72: 193–200
   PubMed Web of Science ®Google Scholar
• Jondorf W. R., Parke D. V., Williams R. T. Studies in Detoxication. 66. The metabolism of halogenobenzenes: 1:2:3-, 1:2:4- and 1:3:5-trichlorobenzenes. Biochem. J. 1955; 61: 512–521
   PubMed Web of Science ®Google Scholar
• Jondorf W. R., Parke D. V., Williams R. T. Studies in Detoxication. 76. The metabolism of halogenobenzenes: 1:2:3:4-, 1:2:3:5, 1:2:4:5-tetrachlorobenzenes. Biochem. J. 1958; 69: 181–189
   PubMed Web of Science ®Google Scholar
• Spencer B., Smith J. N., Williams R. T. Studies in Detoxication. 34. The metabolism of chlorobenzene in the rabbit: Isolation of dihydrodihydroxychlorobenzene, p-chlorophenylglucuronide, 4-chlorocatechol glucuronide, and p-chlorophenylmercapturic acid. Biochem. J. 1950; 47: 284–293
   PubMed Web of Science ®Google Scholar
• Azouz W. M., Parke D. V., Williams R. T. Studies in Detoxication. 42. Fluorobenzene: Spectrophotometric determination of the elimination of unchanged halogenobenzenes by rabbits: A comparison of the oxidation in vivo of fluorobenzene. Biochem. J. 1952; 50: 702–706
   PubMed Web of Science ®Google Scholar
• Parke D. V. Studies in Detoxication 68. The metabolism of 14C-nitrobenzene in the rabbit and guinea pig. Biochem. J. 1956; 62: 339–346
   PubMed Web of Science ®Google Scholar
• Parke D. V. Studies in Detoxication 85. The metabolism of mdinitro-14C-benzene in the rabbit. Biochem. J. 1961; 78: 262–271
   PubMed Web of Science ®Google Scholar
• Parke D. V. Studies in Detoxication 84. The metabolism of [14C]aniline in the rabbit and other animals. Biochem. J. 1960; 77: 493–503
   PubMed Web of Science ®Google Scholar
• Gessner P. K., Parke D. V., Williams R. T. Studies in Detoxication 86. The metabolism of [14C]ethylene glycol. Biochem. J. 1961; 79: 482–488
   PubMed Web of Science ®Google Scholar
• Gessner P. K., Parke D. V., Williams R. T. Studies in Detoxication 80. The metabolism of glycols. Biochem. J. 1960; 74: 1–5
   PubMed Web of Science ®Google Scholar
• Mc W. M., Parke D. V., Williams R. T. Studies in Detoxi cation 77. The metabolism of phenylhydrazine and some phenylhydrazones. Biochem. J. 1958; 70: 697–688
   PubMedGoogle Scholar
• Elliott T. H., Hannam J., Parke D. V., Williams R. T. The metabolism of (1-14C)tetralin in rabbits. Biochem. J. 1964; 92: 52–53P
   Google Scholar
• Kaighen M., Williams R. T. The metabolism of [3-14C]coumarin. J. Med. Pharm. Chem. 1961; 3: 25–43
   Google Scholar
• King L. J., Parke D. V., Williams R. T. The metabolism of [2-14C]indole in the rat. Biochem. J. 1966; 98: 266–277
   PubMed Web of Science ®Google Scholar
• Mead J. A. R., Smith J. N., Williams R. T. Studies in Detoxication 72. The metabolism of coumarin and of o-coumaric acid. Biochem. J. 1958; 68: 67–74
   PubMed Web of Science ®Google Scholar
• Creaven P. J., Parke D. V., Williams R. A spectrofluorimetric study of the 7-hydroxylation of coumarin by liver microsomes. Biochem. J. 1965; 96: 398–390
   Google Scholar
• Bridges J. W., Kibby M. R., Walker S. R., Williams R. T. Species differences in the metabolism of sulphadimethoxine. Biochem. J. 1968; 109: 851–856
   PubMed Web of Science ®Google Scholar
• Baldwin B. S., Robinson D., Williams R. T. The fate of benzoic acid in some domestic and other birds. Biochem. J. 1960; 76: 595–600
   PubMed Web of Science ®Google Scholar
• Clark A. G., Hitchcock M., Smith J. N. Metabolism of gammexane in flies, ticks and locusts. Nature (Lond.) 1966; 209: 103
   PubMed Web of Science ®Google Scholar
• Cohen A. J., Smith J. N. Comparative Detoxication. 9. The metabolism of some halogenated compounds by conjugation with glutathione in the locust. Biochem. J. 1964; 90: 449–456
   PubMed Web of Science ®Google Scholar
• Hitchcock M., Smith J. N. Comparative Detoxication. 13. Detoxication of aromatic acids in arachnids: Arginine, glutamic acid and glutamine conjugations. Biochem. J. 1964; 93: 392–400
   PubMed Web of Science ®Google Scholar
• Booth A. N., Williams R. T. Dehydroxylation of caffeic acid by rat and rabbit caecal contents and sheep rumen liquor. Nature (Lond.) 1963; 198: 684–685
   PubMed Web of Science ®Google Scholar
• Scheline R. R., Wit J. G., Williams R. T. Biological dehydroxylation. Nature (Lond.) 1960; 188: 849–850
   PubMed Web of Science ®Google Scholar
• Adamson R. H., Bridges J. W., Evans M. E. Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem. J. 1970; 116: 437–443
   PubMed Web of Science ®Google Scholar
• Dacre J. C., Scheline R. R., Williams R. T. The role of tissues and gut flora in the metabolism of [14C]-homoprotocatechuic acid in the rat and rabbit. J. Pharm. Pharmacol. 1968; 20: 619–625
   PubMed Web of Science ®Google Scholar
• Williams R. T. Toxicologic implications of biotransformation by intestinal microflora. Toxicol. Appl. Pharmacol. 1972; 23: 769–781
   PubMed Web of Science ®Google Scholar
• Iveson P., Lindup W. E., Parke D. V., Williams R. T. The metabolism of carbenoxolone in the rat. Xenobiotica 1971; 1: 79–95
   PubMedGoogle Scholar
• Millburn P., Smith R. L., Williams R. T. Biliary excretion of foreign compounds: Biphenyl, stilboestrol and phenolphthalein in the rat: Molecular weight, polarity, and metabolism as factors in biliary excretion. Biochem. J. 1967; 105: 1275–1281
   PubMed Web of Science ®Google Scholar
• Abou M. M., Millburn P., Smith R. L., Williams R. T. Biliary excretion of foreign compounds: Species differences in biliary excretion. Biochem. J. 1967; 105: 1289–1293
   PubMed Web of Science ®Google Scholar
• Smith R. L., Caldwell J. Drug metabolism in non-human primates. Drug Metabolism from Microbe to Man, D. V. Parke, R. L. Smith. Taylor and Francis, London 1977; 331–356
   Google Scholar
• Drasar B. S., Renwick A. G., Williams R. T. The role of the gut flora in the metabolism of cyclamate. Biochem. J. 1972; 129: 881–890
   PubMed Web of Science ®Google Scholar
• Renwick A. G., Williams R. T. The fate of cyclamate in man and other species. Biochem. J. 1972; 129: 869–879
   PubMed Web of Science ®Google Scholar
• Parke D. V., Williams R. T. The metabolic fate of drugs. Annu. Rev. Pharmacol. 1964; 4: 85–114
   Google Scholar
• Beckett A. H. Metabolic oxidation of aliphatic basic nitrogen atoms and their α-carbon atoms. Biological Oxidation of Nitrogen in Organic Molecules, J. W. Bridges, J. W. Gorrod, D. V. Parke. Taylor and Francis, London 1972; 53–72
   Google Scholar
• Coutts R. T., Beckett A. H. Metabolic N-oxidation of primary and secondary aliphatic medicinal amines. Drug Metab. Rev. 1977; 6: 51–104
   Web of Science ®Google Scholar
• Pettit F. H., Orme W., Ziegler D. M. The requirement for flavin adenine dinucleotide by a liver microsomal oxygenase catalysing the oxidation of alkylarylamines. Biochem. Biophys. Res. Commun. 1964; 16: 444–448
   PubMed Web of Science ®Google Scholar
• Gorrod J. W. Cytochrome P450 involvement in microsomal N-oxidation. Microsomes, Drug Oxidations and Drug Toxicity, R. Sato, R. Kato. Wiley-Interscience, New York 1982; 621–628
   Google Scholar
• Caldwell J. The metabolism of amphetamines in mammals. Drug Metab. Rev. 1976; 5: 219–280
   PubMed Web of Science ®Google Scholar
• Jenner P. The role of nitrogen oxidation in the excretion of drugs and foreign compounds. Biological Oxidation of Nitrogen in Organic Molecules, J. W. Bridges, J. W. Gorrod, D. V. Parke. Taylor and Francis, London 1972; 87–106
   Google Scholar
• Mitchell S. C., Waring R. H. The early history of xenobiotic sulphoxidation. Drug Metab. Rev. 1985; 16: 284–255
   Google Scholar
• Caldwell J. Conjugation reactions in foreign-compound metabolism: Definition, consequences and species variations. Drug Metab. Rev. 1982; 13: 745–777
   PubMed Web of Science ®Google Scholar
• Pryde J., Williams R. T. The pyranoid structure of glucuronic acid and theophylline arabinoside. Nature (Lond.) 1931; 128: 187
   Google Scholar
• Pryde J., Williams R. T. The biochemistry and physiology of glucuronic acid. I. The structure of glucuronic acid of animal origin. Biochem. J. 1933; 27: 1197–1204
   PubMedGoogle Scholar
• Heminway A., Pryde J., Williams R. T. The biochemistry and physiology of glucuronic acid. Part 5. The site and mechanism of the formation of conjugated glucuronic acid. Biochem. J. 1934; 28: 136–142
   PubMedGoogle Scholar
• Williams R. T. Studies in Detoxication III. The use of the glucuronic acid detoxication mechanism of the rabbit for the resolution of dl-menthol. Biochem. J. 1939; 33: 1519–1524
   PubMedGoogle Scholar
• Williams R. T. Studies in Detoxication. II. (a) The conjugation of isomeric 3-methanols with glucuronic acid and the asymmetric conjugation of dl-menthol and dl-isomenthol in the rabbit. (b) d-Isomenthylglucuronide, a new conjugated glucuronic acid. Biochem. J. 1938; 32: 1849–1855
   PubMedGoogle Scholar
• Garton G. A., Robinson D., Williams R. T. Studies in Detoxication. Part 25. The characterization of phenylglucuronide, and its rate of hydrolysis compared with that of phenylsulphuric acid. Biochem. J. 1949; 45: 65–67
   Web of Science ®Google Scholar
• Garton G. A., Williams R. T. Studies in Detoxication. Part 17. The fate of catechol in the rabbit and the characterization of catechol monoglucuronide. Biochem. J. 1948; 43: 206–211
   Web of Science ®Google Scholar
• Kamil I. A., Smith J. N., Williams R. T. Studies in Detoxication. Part 46. The metabolism of aliphatic alcohols: The glucuronic acid conjugation of acyclic aliphatic alcohols. Biochem. J. 1953; 53: 129–136
   PubMed Web of Science ®Google Scholar
• Kamil I. A., Smith J. N., Williams R. T. Studies in Detoxication. Part 47. The formation of ester glucuronides of aliphatic acids during the metabolism of 2-ethylbutanol and 2-ethylhexanol. Biochem. J. 1953; 53: 127–140
   Google Scholar
• Bridges J. W., Kibby M. R., Williams R. T. The structure of the glucuronide of sulphadimethoxine formed in man. Biochem. J. 1965; 96: 829–836
   PubMed Web of Science ®Google Scholar
• Robinson D., Williams R. T. Do cats form glucuronides?. Biochem. J. 1958; 68: 23
   Web of Science ®Google Scholar
• Mead J. A. R., Smith J. N., Williams R. T. Studies in Detoxication. Part 67. The biosynthesis of the glucuronides of umbelliferone and 4-methylumbelliferone and their use in the fluorimetric determination of β-glucuronidase. Biochem. J. 1956; 61: 569–574
   Web of Science ®Google Scholar
• Dutton G. J., Lawes J. Multiplicity of liver uridine 5′-pyrophosphate glucuronyltransferase from its varying pattern of development with different substrates and species. Biochem. J. 1966; 98: 30
   PubMed Web of Science ®Google Scholar
• Dutton G. J., Langelaan D. E., Ross P. E. High glucuronide synthesis in newborn liver. Choice of species and substrates. Biochem. J. 1964; 93: 4
   Google Scholar
• Burchell B., Jackson M. R., Coughtrie M. W. H., Harding D., Wilson S., Bend J. R. Molecular characterisation of hepatic UDP-glucuronyl transferases. Drug Metabolism from Molecule to Man, D. J. Benford, J. W. Bridges, G. G. Gibson. Taylor and Francis, London 1987; 40–45
   Google Scholar
• Shelswell J., Williams R. T. Studies in Detoxication. 6. Ethereal sulphate formation in the rabbit following the administration of sulphanilamide. Biochem. J. 1940; 34: 528–531
   PubMedGoogle Scholar
• Williams R. T. The influence of o-, and m-, and p-substitution on the sulphate detoxication of phenol in the rabbit. Chem. Ind. 1936; 55: 401
   Google Scholar
• Williams R. T. Studies in Detoxication. I. The influence of (a) dose and (b) o-, m-, and p-substitution on the ethereal sulphate detoxication of phenol in the rabbit. Biochem. J. 1938; 32: 878–887
   PubMedGoogle Scholar
• Robinson D., Smith J. N., Spencer B., Williams R. T. Studies in Detoxication. 43. A study of the arylsulphatase activity of takadiastase towards some phenolic ethereal sulphates. Biochem. J. 1952; 51: 202–208
   PubMed Web of Science ®Google Scholar
• Flynn T. G., Dodgson K. S., Powell G. M., Rose F. A. The metabolism of dipotassium 2-hydroxy-5-nitrophenyl[35S]sulphate, a substrate for aryl sulphatases A and B. Biochem. J., 100 1966; 26
   Google Scholar
• Bray H. G., James S. P., Thorpe W. V. The metabolism of the monochloronitrobenzenes in the rabbit. Biochem. J. 1956; 64: 38–44
   PubMed Web of Science ®Google Scholar
• Bray H. G., James S. P., Thorpe W. V. The metabolism of 2:4-, 2:5-, and 3:4-dichloronitrobenzene in the rabbit. Biochem. J. 1957; 65: 483–490
   PubMed Web of Science ®Google Scholar
• Betts J. J., Bray H. G., James S. P., Thorpe W. V. The metabolism of the trichloronitrobenzenes in the rabbit. Biochem. J. 1957; 66: 610–621
   PubMed Web of Science ®Google Scholar
• Bray H. G., Hybs Z., James S. P., Thorpe W. V. The metabolism of 2:3:5:6- and 2:3:4:5-tetrachloronitrobenzenes in the rabbit and the reduction of aromatic nitrocompounds in the intestine. Biochem. J. 1953; 53: 266–273
   PubMed Web of Science ®Google Scholar
• Betts J. J., James S. P., Thorpe W. V. The metabolism of pentachloronitrobenzene and 2:3:4:6-tetrachloronitrobenzene and the formation of mercapturic acids in the rabbit. Biochem. J. 1955; 61: 611–617
   PubMed Web of Science ®Google Scholar
• Barnes M. M., James S. P., Wood P. B. The formation of mercapturic acids. 1. Formation of mercapturic acids and the levels of glutathione in tissues. Biochem. J. 1959; 71: 680–690
   PubMed Web of Science ®Google Scholar
• Bray H. G., Franklin T. J., James S. P. The formation of mercapturic acids. 2. The possible role of glutathionase. Biochem. J. 1959; 71: 690–696
   PubMed Web of Science ®Google Scholar
• Bray H. G., Franklin T. J., James S. P. The formation of mercapturic acids. 3. N-Acetylation of S-substituted cysteines in the rabbit, rat and guinea pig. Biochem. J. 1959; 73: 465–473
   PubMed Web of Science ®Google Scholar
• Bray H. G., Caygill J. C., James S. P., Wood P. B. Formation of mercapturic acids. 5. Metabolism of some halogenoparaffins and nitroparaffins. Biochem. J. 1964; 90: 127–132
   PubMed Web of Science ®Google Scholar
• Boyland E., Williams K. An enzyme catalysing the conjugation of epoxides with glutathione. Biochem. J. 1965; 94: 190–197
   PubMed Web of Science ®Google Scholar
• Boyland E. The metabolism of foreign compounds and the induction of cancer. Xenobiotica 1986; 16: 899–913
   PubMed Web of Science ®Google Scholar
• Zbarsky S. H., Young L. Mercapturic acids. II. The synthesis of 1-phenylmercapturic acid. J. Biol. Chem. 1943; 151: 211–216
   Google Scholar
• Parke D. V., Williams R. T. Studies in Detoxication. 38. The metabolism of benzene. (a) The determination of phenylmercapturic acid in urine. (b) The mercapturic acid excretion by rabbits receiving benzene. Biochem. J. 1951; 48: 624–629
   PubMed Web of Science ®Google Scholar
• Parke D. V. Studies in Detoxication. 64. The synthesis of the isomeric dichlorophenylmercapturic acids. Biochem. J. 1954; 59: 422–426
   Web of Science ®Google Scholar
• Chasseaud L. F. The nature and distribution of enzymes catalysing the conjugation of glutathione with foreign compounds. Drug Metab. Rev. 1974; 2: 185–220
   Web of Science ®Google Scholar
• Hayes J. D., Mc L. I., Stockman P. K., Chalmers J., Howie A. F., Hussey A. J., Beckett G. J. Human glutathione S-transferases. Drug Metabolism—From Molecules to Man, D. J. Benford, J. W. Bridges, G. G. Gibson. Taylor and Francis, London 1987; 82–94
   Google Scholar
• Parke D. V. Eric Boyland—A pioneer in cancer biochemistry. Xenobiotica 1986; 16: 887–898
   PubMed Web of Science ®Google Scholar
• Boyland E., Levi A. A. Metabolism of polycyclic compounds. I. Production of dihydroxyanthracene from anthracene. Biochem. J. 1935; 29: 2679–2683
   PubMedGoogle Scholar
• Boyland E., Warren F. L. Induction of tumours by methylcholanthrene in two strains of mice. J. Pathol. Bact. 1937; 45: 171–177
   Google Scholar
• Boyland E., Sims P. Metabolism of polycyclic compounds. XVI. The metabolism of 1,2-dihydroxynaphthalene and 1,2-epoxy-1,2,3,4-tetrahydronaphthalene. Biochem. J. 1960; 77: 175–181
   PubMed Web of Science ®Google Scholar
• Grover P. L. Pathways involved in the metabolism and activation of polycyclic hydrocarbons. Xenobiotica 1986; 16: 915–931
   PubMed Web of Science ®Google Scholar
• Sims P., Grover P. L., Swaisland A., Pal K., Hewer A. Metabolic activation of benzo(a)pyrene proceeds via a diol epoxide. Nature (Lond.) 1974; 252: 326–328
   PubMed Web of Science ®Google Scholar
• Jerina D. M., Daly J. W. Oxidation at carbon. Drug Metabolism from Microbe to Man, D. V. Parke, R. L. Smith. Taylor and Francis, London 1977; 13–32
   Google Scholar
• Boyland E., Manson D. Biochemistry of aromatic amines. V. 2-Acetamido-6-hydroxy-5-naphthyl hydrogen sulphate and other metabolites of 2-naphthylamine and 2-acetamidonaphthylamine. Biochem. J. 1958; 69: 601–605
   PubMed Web of Science ®Google Scholar
• Gorrod J. W., Manson D. The metabolism of aromatic amines. Xenobiotica 1986; 16: 933–955
   PubMed Web of Science ®Google Scholar
• Boyland E. Biochemical mechanisms of induction of bladder cancer. Ciba Foundation Symposium, Carcinogenesis 1958; 218–229
   Google Scholar
• Boyland E. The mechanism of tumour induction by aromatic amines and other carcinogens. Z. Krebsforschung 1963; 65: 378–384
   PubMedGoogle Scholar
• Fabro S., Schumacher H., Smith R. L., Williams R. T. Teratogenic activity of thalidomide and related compounds. Life Sci. 1964; 3: 987–992
   PubMed Web of Science ®Google Scholar
• Fabro S., Schumacher H., Smith R. L., Williams R. T. Identification of thalidomide in rabbit blastocysts. Nature (Lond.) 1964; 201: 1125–1126
   PubMed Web of Science ®Google Scholar
• Fabro S., Smith R. L., Williams R. T. The fate of [14C]thalidomide in the pregnant rabbit. Biochem. J. 1967; 104: 565–569
   PubMed Web of Science ®Google Scholar
• Williams R. T. Thalidomide—A study of biochemical teratology. Arch. Environ. Health 1968; 16: 493–502
   PubMed Web of Science ®Google Scholar
• Thorpe W. V., Williams R. T. Isolation of acetylsulphathiazole from human and rat urines following administration of 760. Nature (Lond.) 1940; 146: 686–687
   Google Scholar
• Wills E. D., Wilkinson A. E. Release of enzymes from lysosomes by irradiation and the relation of lipid peroxide formation to enzyme release. Biochem. J. 1966; 99: 657–666
   PubMed Web of Science ®Google Scholar
• Cox P. J., King L. J., Parke D. V. The binding of trichlorofluoromethane and other haloalkanes to cytochrome P450 under aerobic and anaerobic conditions. Xenobiotica 1976; 6: 363–376
   PubMed Web of Science ®Google Scholar
• Slater T. F. Necrogenic action of carbon tetrachloride in the rat: A speculative mechanism based on activation. Nature (Lond.) 1966; 209: 36–40
   PubMed Web of Science ®Google Scholar
• Price D. A. Individual variations of drug metabolism as a factor in drug toxicity. Ann. NY Acad. Sci. 1965; 123: 178–187
   PubMed Web of Science ®Google Scholar
• Price D. A. Drug metabolism and human genetics. Drug Metabolism in Man, J. W. Gorrod, A. H. Beckett. Taylor & Francis, London 1972; 135–145
   Google Scholar
• Idle R. R., Smith R. L. Polymorphisms of oxidation at carbon centres of drugs and their clinical significance. Drug Metab. Rev. 1979; 9: 301–317
   PubMed Web of Science ®Google Scholar
• Breckenridge A., Bending M. R., Brunner G. Impact of drug monooxygenases in clinical pharmacology. Microsomes and Drug Oxidations, V. Ullrich, I. Roots, A. Hildebrandt, R. W. Estabrook, A. H. Conney. Pergamon Press, Oxford 1976; 385–394
   Google Scholar
• Cunningham J. L., Bullen M. F., Price D. A. The pharmacogenetics of acetanilide and diphenylhydantoin sodium. Eur. J. Clin. Pharmacol. 1975; 7: 461–466
   Web of Science ®Google Scholar
• Davies D. S., Thorgeirsson S. S., Breckenridge A., Orme M. Inter-individual differences in rates of drug oxidation in man. Drug Metab. Rev. 1973; 1: 411–416
   Google Scholar
• Hall D. E., Mulder D. E., Steele C. M., Spicket J., Delaforge M. A comparison of the protective effects of N-acetylcysteine and S-carboxymethylcysteine against paracetamol-induced hepatotoxicity. Toxicology 1983; 28: 313–321
   PubMed Web of Science ®Google Scholar
• Ioannides C., Steele C. M., Parke D. V. Species variation in the metabolic activation of paracetamol to toxic intermediates. Role of cytochromes P-450 and P-448. Toxicol. Lett. 1983; 16: 55–61
   PubMed Web of Science ®Google Scholar
• Clarke A. J., Clark B., Eason C. T., Parke D. V. An assessment of a toxicological incident in a drug development program and its implications. Regulat. Toxicol. Pharmacol. 1985; 5: 109–119
   PubMed Web of Science ®Google Scholar
• Eason C. T., Clark B., Smith D. A., Parke D. V. The mechanism of hepatotoxicity of a chromone carboxylic acid (FPL 52757). Xenobiotica 1982; 12: 155–164
   PubMed Web of Science ®Google Scholar
• Ayrton A. D., Ioannides C. Parke Induction of cytochrome P450I and IV families and peroxisomal proliferation in the liver of rats treated with benoxaprofen. Possible implications in its hepatotoxicity. Biochem. Pharmacol. 1991; 42: 115–109
   Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. A retrospective study of the molecular toxicology of benoxaprofen. Toxicology 1991; 65: 33–47
   Web of Science ®Google Scholar
• Park B. K., Kitteringham N. R. Drug-protein conjugation and its immunological consequences. Drug Metab. Rev. 1990; 22: 87–144
   PubMed Web of Science ®Google Scholar
• Parke A., Lewis D. F. V., Ioannides C., Parke D. V. Molecular pathology of drug-disease interactions in chronic autoimmune inflammatory diseases. Inflammopharmacology 1991; 1: 3–36
   Google Scholar
• Neuberger J., Williams R. Immune mechanisms in tienilic acid associated hepatotoxicity. Gut 1989; 30: 515–519
   PubMed Web of Science ®Google Scholar
• Parke D. Reactive intermediates and mechanisms of toxicity. Microsomes, Drug Oxidations and Drug Toxicity, R. Sato, R. Kato. Wiley-Interscience, New York 1982; 447–452
   Google Scholar
• Preece N. E., Hall D. E., Howarth J. A., King L. J., Parke D. V. Effects of acute and sub-chronic administration of iron nitriloctriacetate in the rat. Toxicology 1989; 59: 37–58
   PubMed Web of Science ®Google Scholar
• Dowling E. J., Symons A. M., Parke D. V. Free radical production at the site of acute inflammatory reaction as measured by chemiluminescence. Agents Actions 1986; 19: 203–207
   PubMedGoogle Scholar
• Preece N. E., Evans P. F., Howarth J. A., King L. J. The induction of autoxidative tissue damage by iron nitrilotriacetate in rats and mice. Toxicol. Appl. Pharmacol. 1988; 93: 89–100
   PubMed Web of Science ®Google Scholar
• Preece N. E., Evans P. F., King L. J., Parke D. V. Effects of glutathione depletion, chelation and diuresis on iron nitrilotriacetateinduced lipid peroxidation in rats and mice. Xenobiotica 1990; 20: 879–886
   PubMed Web of Science ®Google Scholar
• Yardley A., Anderson D., Parke D. V. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br. J. Indust. Med. 1991; 48: 437–444
   PubMedGoogle Scholar
• Parke D. V. Mechanisms of chemical carcinogenesis. Environ. Health Perspect. 1994; 102: 852–853
   PubMed Web of Science ®Google Scholar
• Parke A., Parke D. V. The pathogenesis of inflammatory disease: Surgical shock and multiple system organ failure. Inflammopharmacology 1995; 3: 149–168
   Google Scholar
• Liu P. T., Kentish P. A., Symons A. M., Parke D. V. The effects of ether anaesthesia on oxidative stress in rats—Dose response. Toxicology 1993; 80: 37–49
   PubMed Web of Science ®Google Scholar
• Liu P. T., Symons A. M., Howarth J. A., Boulter P. S., Parke D. V. Studies in surgical trauma: oxidative stress in ischaemia—Reperfusion of rat liver. Clin. Sci. 1994; 86: 453–460
   PubMed Web of Science ®Google Scholar
• Breaker P. J., Ioannides C., Taylor I., Parke D. V. Species differences and rates of mixed-function oxidation. Microsomes, Drug Oxidations and Drug Toxicity, R. Sato, R. Kato. Wiley-Interscience, New York 1982; 403–404
   Google Scholar
• Walker C. H. Species differences in microsomal monoxygenase activity and their relationship to biological half-lives. Drug Metab. Rev. 1978; 7: 295–323
   PubMed Web of Science ®Google Scholar
• Booth J., Boyland E., Cooling C. The respiration of human liver tissue. Biochem. Pharmac. 1967; 16: 721–724
   PubMed Web of Science ®Google Scholar
• Parke D. V. Toxicological consequences of enzyme induction and inhibition. Drug Toxicity, J. W. Gorrod. Taylor and Francis, London 1979; 133–150
   Google Scholar
• Ioannides C., Parke D. V. Mechanism of induction of hepatic microsomal drug-metabolizing enzymes by a series of barbiturates. J. Pharm. Pharmacol. 1975; 27: 739–746
   PubMed Web of Science ®Google Scholar
• Parke D. V. Induction of drug-metabolizing enzymes. Enzyme Induction, D. V. Parke. Plenum Press, London 1975; 207–271
   Google Scholar
• Ioannides C., Lake B. G., Parke D. V. Enhancement of hepatic microsomal drug metabolism in vitro following ethanol administration. Xenobiotica 1975; 5: 665–676
   PubMed Web of Science ®Google Scholar
• Labadarios D., Dickerson J. W. T., Lucas E. G., Obuwa G. H., Parke D. V. The effects of chronic drug administration on hepatic enzyme induction and folate metabolism. Br. J. Clin. Pharmacol. 1978; 5: 167–173
   PubMed Web of Science ®Google Scholar
• Lum P. Y., Ioannides C., Parke D. V. Cytochrome P-448 and the activation of toxic chemicals and carcinogens. Xenobiotica 1984; 14: 119–137
   PubMed Web of Science ®Google Scholar
• Creaven P. J., Parke D. V. The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds. Biochem. Pharmacol. 1966; 15: 7–16
   PubMed Web of Science ®Google Scholar
• Phillipson C. E., Godden P. M. M., Lum P. Y., Ioannides C., Parke D. V. Determination of cytochrome P-448 activity in biological tissues. Biochem. J. 1984; 221: 81–88
   PubMed Web of Science ®Google Scholar
• Mc F. J., Bridges J. W., Parke D. V. The effects of benzopyrene and safrole on biphenyl 2-hydroxylase and other drug-metabolising enzymes. Biochem. J. 1976; 154: 773–780
   PubMed Web of Science ®Google Scholar
• Delaforge M., Ioannides C., Parke D. V. The inhibition of cytochrome P-448 mixed-function oxidase activity following administration of 9-hydroxyellipticine to rats. Chem-Biol. Interact. 1980; 32: 101–110
   PubMed Web of Science ®Google Scholar
• Iwasaki K., Lum P. Y., Ioannides C., Parke D. V. Induction of cytochrome P-448 activity as exemplified by the O-deethylation of ethoxyresorufin. Effects of dose, sex, tissue and animal species. Biochem. Pharmacol. 1986; 35: 3879–3884
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Physical methods in the study of the active site geometry of cytochromes P450. Drug Metab. Rev. 1986; 17: 1–66
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Structural requirements for substrates of cytochromes P-450 and P-448. Chem.-Biol. Interact. 1987; 64: 39–60
   PubMed Web of Science ®Google Scholar
• Ioannides C., Parke D. V. Commentary. The cytochromes P-448—A unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochem. Pharmacol. 1987; 36: 4197–4207
   PubMed Web of Science ®Google Scholar
• Ioannides C., Parke D. V. The cytochrome P450I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab. Rev. 1990; 22: 1–85
   PubMed Web of Science ®Google Scholar
• Ioannides C., Parke D. V. Induction of cytochrome P4501 as an indicator of potential carcinogenesis. Drug Metab. Rev. 1993; 25: 485–501
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Molecular dimensions of the substrate binding site of cytochrome P-448. Biochem. Pharmacol. 1986; 35: 2179–2185
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP. Mutat. Res. 1993; 291: 61–77
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Moereels A., Lake B. G., Ioannides C., Parke D. V. Molecular modelling of enzymes and receptors involved in carcinogenesis: QSARs and COMPACT-3D. Drug Metab. Rev. 1994; 26: 261–285
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Molecular modelling of cytochrome CYP1A1: A putative access channel explains the difference in induction potency between the isomers benzo(a)pyrene and benzo(e)pyrene, and 2- and 4-acetylaminofluorene. Toxicol. Lett. 1994; 71: 235–243
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Walker R., Parke D. V. Quantitative structure-activity relationships and COMPACT analysis of a series of food mutagens. Food Addit. Contam. 1995; 12: 715–723
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Cytochromes P450—Structure, Function and Mechanism. Taylor Francis, London 1996
   Google Scholar
• Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab. Rev. 1987; 18: 441–515
   PubMed Web of Science ®Google Scholar
• Gibson G. G. Co-induction of cytochrome P4504A 1 and peroxisome proliferations: A causal or casual relationship?. Xenobiotica 1992; 22: 1101–1109
   PubMed Web of Science ®Google Scholar
• Peters M. C. G., Walters D. G., Van B., Van P. J., Lake B. G. Effect of inducers of cytochrome P450 on the metabolism of [3-14C]coumarin by rat hepatic microsomes. Xenobiotica 1991; 21: 499–514
   PubMed Web of Science ®Google Scholar
• Lake B. G., Tredger J. M., Gray T. J. B., Stubberfield C. R., Hodder K. D., Gangoli S. D., Williams R. The effect of peroxisome prolifators on the metabolism and spectral interaction of endogenous substrates of cytochrome P-450 in rat hepatic microsomes. Life Sci. 1984; 35: 2621–2626
   PubMed Web of Science ®Google Scholar
• Lake B. G., Lewis D. F. V. The CYP4 family. Cytochromes P450: Metabolic and Toxicological Aspects, C. Ioannides. CRC Press, New York 1996; 271–297
   Google Scholar
• Eason C. T., Bonner F. W., Parke D. V. The importance of pharmacokinetic and receptor studies in drug safety evaluation. Regulat. Toxicol. Pharmacol. 1990; 11: 288–307
   PubMed Web of Science ®Google Scholar
• Berry D. J., Webley M., Grahame R., Goulding R., Gaetani M., Parke D. V. Pharmacokinetics of single oral doses of feprazone in patients with rheumatoid arthritis or with impaired renal clearance. Xenobiotica 1231; 23: 1240–1993
   Google Scholar
• May D. G., Black C. M., Olsen N. J., Csuka M. E., Tanner S. B., Bellino L., Porter J. A., Wilkinson G. R., Branch R. A. Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquine and mephenytoin. Clin. Pharamcol. Ther. 1990; 48: 295–286
   PubMedGoogle Scholar
• Mulders T. M. T., Keizer H. J., Breimer D. D., Mulder G. J. In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients. Drug Metab. Rev. 1995; 27: 229–191
   Google Scholar
• Vouk V. B., Butler G. C., Upton A. C., Parke D. V., Asher S. C. Methods for Assessing the Effects of Mixture of Chemicals. Wiley, Chichester 1987, SCOPE 30, SGOMSEC 3, IPCS Joint Symposia 6
   Google Scholar
• Parke A. L., Parke D. V. Chemical-induced inflammation diseases. Int. J. Occup. Med. Environ. Health 1996; 9: 218–211
   Google Scholar
• Piotrowski J. K., Parke D. V. Glutathione: Its role in the detoxication of reactive oxygen and environmental chemicals. Acta Pol. Toxicol., 14: 14–1996
   Google Scholar
• Lake B. G. Mechanisms of carcinogenicity of peroxisome-proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol. 1995; 35: 507–483
   Google Scholar
• Parke D. V., Elstein M. Mucus in Health and Disease. Plenum Press, New York 1977
   Google Scholar
• Nelson D. R., Strobel H. W. Evolution of cytochrome P-450 proteins. Mol. Biol. Evolut. 1987; 4: 593–572
   Google Scholar